Thursday 6 November 2014

FDA Advisers Say 'No' to Myeloma Drug

(MedPage Today) -- Oncologic Drugs Advisory Committee voted against panobinostat for relapsed or refractory myeloma. via MedPageToday.com - medical news plus CME for physicians Read More Here..
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)